In a filing, Abbott Laboratories revealed its Director Blount Sally E. unloaded Company’s shares for reported $0.34 million on Apr 30 ’25. In the deal valued at $129.66 per share,2,600 shares were sold. As a result of this transaction, Blount Sally E. now holds 34,058 shares worth roughly $4.24 million.
Then, SALLY E BLOUNT bought 2,600 shares, generating $337,116 in total proceeds.
Before that, Earnhardt Lisa D sold 91,167 shares. Abbott Laboratories shares valued at $12,199,968 were divested by the EVP AND GROUP PRESIDENT at a price of $133.82 per share. As a result of the transaction, Earnhardt Lisa D now holds 71,928 shares, worth roughly $8.95 million.
Jefferies upgraded its Abbott Laboratories [ABT] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in mid June with a ‘”a Market perform”‘ rating. Oppenheimer began covering ABT with “an Outperform” recommendation on October 08, 2024. Piper Sandler started covering the stock on September 19, 2024. It rated ABT as “an Overweight”.
Price Performance Review of ABT
On Monday, Abbott Laboratories [NYSE:ABT] saw its stock jump 0.61% to $124.42. Over the last five days, the stock has lost -5.76%. Abbott Laboratories shares have risen nearly 18.86% since the year began. Nevertheless, the stocks have risen 10.00% over the past one year.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2025-06-13, dropping by -1.46 million shares to a total of 20.8 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 22.26 million shares. There was a decline of -7.0%, which implies that there is a negative sentiment for the stock.
